Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Mayo Clinic discovery on nature of rheumatoid arthritis lung disease may offer patients therapy

10.01.2005


A discovery by a Mayo Clinic research team may pave the way for the creation of new drugs to treat rheumatoid arthritis (RA) lung disease, which affects an estimated 500,000 patients in the United States. Currently, there are no effective treatments for RA lung disease.

In a paper that appears in today’s online version of the Jan. 13 edition of Arthritis & Rheumatism, the researchers report that RA lung disease may operate much differently from other forms of lung disease. If further studies support this finding, it could change the way RA lung disease is treated as well as the design focus of drugs developed to treat it.

The Mayo Clinic research paper describes a staining method the team refined for identifying markers in RA patients’ lung tissues. The results establish two key points never before fully documented in the laboratory:

  • Certain specific T cells of the immune system, whose normal job in healthy people is to attack disease organisms that invade the body, are more abundant in tissue samples from patients with RA lung disease than in tissue samples from patients who have other forms of lung disease. This finding supports the concept that RA lung disease may be fundamentally different from other forms of lung disease -- and should be treated differently.


  • RA lung disease detection can be improved through the technological advance of computer-assisted image analysis. This improvement allows the disease to be diagnosed early and treated aggressively as a disease of the immune system.

Many doctors who have seen our results say, ’This is what I’ve always believed.’ But no one had proved it to them," says Carl Turesson, M.D., Ph.D., former Mayo Clinic research fellow now working at Malmo University Hospital in Sweden. Says Dr. Turesson, "Our work provides the evidence that was lacking, so from that standpoint, it is a very helpful demonstration that hopefully will lead to the development of new treatment strategies for RA lung disease."

The Investigation

In the Mayo Clinic laboratories, Dr.Turesson and colleagues examined 31 lung tissue biopsy specimens. Of those, 15 were from patients previously diagnosed with RA lung disease, and 16 were from patients who, although not suffering from RA lung disease, also had a disease affecting the lung tissue, interstitial lung disease. No one on the research team knew the diagnosis of a given specimen. All specimens were stained to enhance certain T cell subtypes and then examined by digital images magnified 100 times. The staining patterns were quantified using computer-assisted image analysis. Results from the 11,412 images analyzed indicated that tissue samples from RA lung disease patients consistently showed elevated numbers of a subset of T cells known as CD4 and CD3 cells.

Practical Implications of the Research

At least two immediate implications of this research could change the way researchers are attempting to design RA lung disease drugs and how aggressively RA lung disease patients are treated. First, the abundance of CD4 and CD3 cells in RA lung disease tissue suggests therapies specifically directed against T cells and T cell function may succeed where earlier therapeutic approaches did not. Explains Dr. Turesson: "This is a rationale for trying newer approaches to treating RA lung disease that involve drugs that block T cell action. That might help us make progress against this disease." Studies are ongoing to examine other important subtypes of cells involved in RA lung disease and to discover how these are related to its cause and the damage to the joints, lungs and other tissues of the body which result.

Second, data from the researchers shows that the form of RA disease that spreads beyond joints to involve the lungs is more likely to be fatal. However, if physicians can use the Mayo Clinic method for detecting early telltale signs of RA lung disease, they can decide to treat the disease aggressively in its early stages and thus potentially prolong lives, according to Dr. Turesson.

About Rheumatoid Arthritis

Rheumatoid arthritis belongs to a class of diseases in which the immune system erroneously attacks the body. These are called "autoimmune" diseases. Because it is a systemwide disorder that can affect different parts of the body, RA can cause a variety of symptoms. It can work silently for years without symptoms, as in the early stages of both joint damage and RA lung disease. Symptoms can include joint pain, stiffness, inflammation, persistent cough, shortness of breath and fever. RA affects an estimated 1 percent of the U.S. population, about 2.1 million Americans, according to the Arthritis Foundation, http://www.arthritis.org. Of these, nearly one-half may have some abnormal lung function. Up to one-fourth -- about 500,000 Americans -- develop RA lung disease. In RA lung disease, the air sacs of the lung (alveoli) and the structures that support them become so damaged by inflammation that they become scarred, impairing effective lung functioning.

Collaboration and Support

In addition to Dr. Turesson, other Mayo Clinic investigators included: Eric Matteson, M.D.; Thomas Colby, M.D.; Zvezdana Vuk-Pavlovic, Ph.D.; Robert Vassallo, M.D.; Henry Tazelaar, M.D.; and Andrew Limper, M.D. Cornelia Weyand, M.D., Ph.D., former Mayo Clinic rheumatologists, now working at Emory University in Atlanta, also collaborated.

Lisa Lucier | EurekAlert!
Further information:
http://www3.interscience.wiley.com/cgi-bin/jtoc/76509746/

More articles from Health and Medicine:

nachricht New antibody analysis accelerates rational vaccine design
09.08.2018 | Scripps Research Institute

nachricht Distrust of power influences choice of medical procedures
01.08.2018 | Johannes Gutenberg-Universität Mainz

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

Im Focus: Lining up surprising behaviors of superconductor with one of the world's strongest magnets

Scientists have discovered that the electrical resistance of a copper-oxide compound depends on the magnetic field in a very unusual way -- a finding that could help direct the search for materials that can perfectly conduct electricity at room temperatur

What happens when really powerful magnets--capable of producing magnetic fields nearly two million times stronger than Earth's--are applied to materials that...

Im Focus: World record: Fastest 3-D tomographic images at BESSY II

The quality of materials often depends on the manufacturing process. In casting and welding, for example, the rate at which melts solidify and the resulting microstructure of the alloy is important. With metallic foams as well, it depends on exactly how the foaming process takes place. To understand these processes fully requires fast sensing capability. The fastest 3D tomographic images to date have now been achieved at the BESSY II X-ray source operated by the Helmholtz-Zentrum Berlin.

Dr. Francisco Garcia-Moreno and his team have designed a turntable that rotates ultra-stably about its axis at a constant rotational speed. This really depends...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

2018 Work Research Conference

25.07.2018 | Event News

 
Latest News

'Building up' stretchable electronics to be as multipurpose as your smartphone

14.08.2018 | Information Technology

During HIV infection, antibody can block B cells from fighting pathogens

14.08.2018 | Life Sciences

First study on physical properties of giant cancer cells may inform new treatments

14.08.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>